IVD Quality Controls Market: Steady Growth Driven by Innovation and Standardization
The In Vitro Diagnostic (IVD) quality controls market is poised for steady growth, valued at an estimated USD 1.65 billion in 2025 and projected to reach USD 2.15 billion by 2030, growing at a CAGR of 5.5% during the forecast period. Several factors are fueling this expansion, reflecting both the evolving needs of clinical laboratories and the broader trends in global healthcare diagnostics.
Key...
IVD Quality Controls Market – Top Players and Growth Strategies
According to research report the global IVD
quality control market is expected to reach USD 1.04 billion by
2022, at a CAGR of 3.5% from 2017 to 2022. The global IVD quality controls market
is oligopolistic in nature with very few players accounting for a major share
of the market. Bio-Rad Laboratories, Inc. (U.S.), Randox Laboratories (U.K.),
and Thermo Fisher Scientific, Inc. (U.S.) are the major...